What's new

Human medicines European public assessment report (EPAR): Prasugrel Viatris (previously Prasugrel Mylan), prasugrel, Date of authorisation: 15/05/2018, Revision: 11, Status: Authorised

Human medicines European public assessment report (EPAR): Prasugrel Viatris (previously Prasugrel Mylan), prasugrel, Date of authorisation: 15/05/2018, Revision: 11, Status: Authorised

Mar 25, 2025 - 17:13
 0
Human medicines European public assessment report (EPAR): Prasugrel Viatris (previously Prasugrel Mylan), prasugrel, Date of authorisation: 15/05/2018, Revision: 11, Status: Authorised
Human medicines European public assessment report (EPAR): Prasugrel Viatris (previously Prasugrel Mylan), prasugrel, Date of authorisation: 15/05/2018, Revision: 11, Status: Authorised
Read More

Tags:

Previous Article

Merck bets $200M on a new type of heart pill

Next Article

Checking In: Squier’s Seeks to Marry Craft, Convenience with New RTDs

Related Posts

Orphan designation: adeno-associated virus sector serotype rh74 containing the human SGCG gene Treatment of limb-girdle muscular dystrophy, 27/02/2025 Positive

Orphan designation: adeno-associated virus sector serot...

Mar 11, 2025  0

Budesonide, prolonged release tablets, 9 mg product- specific bioequivalence guidance

Budesonide, prolonged release tablets, 9 mg product- sp...

Feb 12, 2025  0

Type-IB variations: questions and answers

Type-IB variations: questions and answers

Feb 18, 2025  0